...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Questrade

Anyone know why my bids are being rejected by questrade?  They are limit orders @ .10 for 10,000 shares.  Questrade is asking that they be modified in order to try again. 

thanks 

Share
New Message
Please login to post a reply